Please use this identifier to cite or link to this item: doi:10.22028/D291-36789
Volltext verfügbar? / Dokumentlieferung
Title: Easy measurement of health related quality of life in patients with cystic fibrosis by the COPD assessment test (CAT) : A pilot study
Author(s): Pott, Julian
Krill, Angelika
Wilkens, Heinrike
Bals, Robert
Language: English
Title: Respiratory Medicine
Volume: 168
Publisher/Platform: Elsevier
Year of Publication: 2020
Free key words: Cystic fibrosis
Quality of live
Patient related outcome
Questionnaire
COPD
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Background: Quality of life (QOL) is an important patient-related outcome (PRO) in patients with cystic fibrosis (CF). There are several QOL questionnaires like the “Cystic Fibrosis Questionnaire Revised” (CFQ-R) or the “St George’s Respiratory Questionnaire” (SGRQ) that are well validated in CF. The aim of the study was to evaluate whether the easily applicable “COPD assessment test” (CAT) can be used in CF patients. Methods: 42 CF patients were recruited within the PulmoHOM study, a prospective, observational cohort study. The CAT, the SGRQ and the CFQ-R were handed out to the patients. The spearman’s rank correlation coefficient and the Cronbach’s α coefficient were used for the statistical analysis. Results: The internal consistencies of the CAT, SGRQ and the CFQ-R were high (Cronbach’s α coefficients ¼ 0.89, 0.91 and 0.83). There were significant correlations between the CAT and the total score of the SGRQ (r ¼ 0.851, p < 0.01), between the CAT and many items of the CFQ-R (physical score of the CFQ-R and total score of the CAT: r ¼ 0.872, p < 0.01) and between the SGRQ and the CFQ-R (physical score of the CFQ-R and total score of the SGRQ: r ¼ 0.878, p < 0.01). Conclusion: The main finding was the high correlation between the CAT and the validated questionnaires in CF. The CAT is a PRO instrument that can be filled quickly and that correlates well with the CFQ-R. The CAT or similar tools might be applicable in the care of CF patients.
DOI of the first publication: 10.1016/j.rmed.2020.105992
URL of the first publication: https://www.sciencedirect.com/science/article/pii/S0954611120301323
Link to this record: urn:nbn:de:bsz:291--ds-367892
hdl:20.500.11880/33424
http://dx.doi.org/10.22028/D291-36789
ISSN: 0954-6111
Date of registration: 12-Jul-2022
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Robert Bals
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.